Back to today’s briefing

Story perspectives

Statins: No ALS Survival Impact, But Lower Dementia Risk

4/3/2025

48 5

Summary

Story summary

A groundbreaking Norwegian study reveals that statins have no impact on survival rates for ALS patients, indicating they shouldn't be automatically stopped after diagnosis. In a related finding, statins may lower dementia risk by 13% in those with low "bad" cholesterol, highlighting the crucial link between cholesterol management and cognitive well-being.

1 of 1

Story summary

A groundbreaking Norwegian study reveals that statins have no impact on survival rates for ALS patients, indicating they shouldn't be automatically stopped after diagnosis. In a related finding, statins may lower dementia risk by 13% in those with low "bad" cholesterol, highlighting the crucial link between cholesterol management and cognitive well-being.